Speakers cramp new disorder treated with Botox

NewsGuard 100/100 Score

A research team in Copenhagen, Denmark have named a speech disorder "Speaker's Cramp".

The condition causes a task-related spasmodic contraction of the muscles of the mouth and jaw, which in turn creates involuntary movements of the mouth and lips which only happens during speech, manifesting as grimacing and sound distortion. Symptoms were reduced when the affected muscles were treated with Botox injections.

Patients rated their speech difficulties on visual analogue scales, and video recordings for dystonia scores and neurological and odontological examinations were used for evaluation. Surface and needle electromyography (EMG) was applied to locate dystonic activity and guide injections of Botox into the affected muscles. After baseline recordings, the patients were followed for two to three years, with Botox injections every 3-4 months and evaluation once or twice between treatments. The level of digastric muscle activity was directly linked to the severity of the condition. The patients reported marked improvement in and relief from the grimacing and speech difficulty associated with Speaker's Cramp after treatment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis